Tilo Kölbel,Sebastian W Carpenter,Anusch Taraz et al.
Tilo Kölbel et al.
Background: The aim of this paper was to present a mathematical model to calculate the required main aortic graft-diameter for parallel chimney-grafts. Me...
Outcome of extensive descending aorta repair adopting present concepts of spinal cord preservation [0.03%]
采用目前脊髓保存理念行降主动脉广泛置换的临床效果
Kay H Park,Cheong Lim,Tae H Kim et al.
Kay H Park et al.
Background: Preoperative radiological identification of the Adamkiewicz artery and intraoperative neurologic monitoring are known to be helpful for preventing paraplegia after thoracoabdominal aorta replacement. To answer...
Transcranial Doppler and diffusion-weighted magnetic resonance evaluation of cerebral embolization occurring during transfemoral carotid stenting with proximal flow blockage [0.03%]
经股动脉颈内动脉支架植入术中近端血管阻断时脑栓塞的发生经颅多普勒和弥散加权磁共振的评价
Giovanni Palombo,Nazzareno Stella,Cristiano Fantozzi et al.
Giovanni Palombo et al.
Background: Transfemoral carotid artery stenting (CAS) with endovascular proximal flow blockage is deemed able to reduce the cerebral embolization observed during filter-protected CAS. We evaluated clinical outcome and in...
Klaus Mathias
Klaus Mathias
The management of acute stroke has changed in the recent past due to the superior results of thrombectomy in patients with occlusion of larger brain supplying arteries in comparison to intravenous thrombolysis. This progress is mainly based...
Klaus Mathias
Klaus Mathias
The management of acute stroke has changed in the recent past due to the superior results of thrombectomy in patients with occlusion of larger brain supplying arteries in comparison to intravenous thrombolysis. This progress is mainly based...
Leonardo Rangel-Castilla,Kenneth V Snyder,Adnan H Siddiqui et al.
Leonardo Rangel-Castilla et al.
Acute ischemic stroke (AIS) is the leading cause of long-term disability and the second cause of death worldwide. Intravenous (IV) tissue plasminogen activator (tPA) remains the only FDA-approved treatment for AIS. The use of IV tPA in AIS ...
Carotid interventions (CEA and CAS) in acute stroke patients: which procedure on which patient [0.03%]
急性卒中患者颈动脉内膜剥脱术和支架成形术的选择及适用人群
Ralph C Darling rd,Courtney Warner,Chin C Yeh et al.
Ralph C Darling rd et al.
Treatment of carotid bifurcation disease in patients presenting with acute stroke has been a controversial issue over the past four decades. Classically, patients were asked to wait four to six weeks before intervention was entertained in o...
What are the potential limitations of drug coated balloons and possible ways to overcome [0.03%]
药物涂层球囊的潜在局限性及可能的解决方法
Michael Werk
Michael Werk
In several independent randomized clinical studies, it has been shown that drug-coated balloons (DCBs) cause persistent clinically meaningful and statistically significant inhibition of restenosis in femoropopliteal arteries in comparison t...
Fabrizio Fanelli,Alessandro Cannavale
Fabrizio Fanelli
Patients with infrapopliteal arterial disease are generally considered challenging due to the usual presence of multivessel atherosclerotic disease. Several treatment options have been used by different authors but none of them can be consi...
Leonado Marques,Silke Hopf-Jensen,Stefan Müller-Hülsbeck
Leonado Marques
Having evolved at a rapid pace, the therapy options for percutaneous treatment of peripheral arterial disease in the lower limbs, especially percutaneous transluminal angioplasty in combination with stent-technology, are able to deliver a r...